1. Home
  2. HLF vs OGN Comparison

HLF vs OGN Comparison

Compare HLF & OGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Herbalife Ltd.

HLF

Herbalife Ltd.

HOLD

Current Price

$15.50

Market Cap

2.1B

Sector

Health Care

ML Signal

HOLD

Logo Organon & Co.

OGN

Organon & Co.

HOLD

Current Price

$6.40

Market Cap

1.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HLF
OGN
Founded
1980
1923
Country
United States
United States
Employees
N/A
10000
Industry
Other Pharmaceuticals
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.1B
1.7B
IPO Year
2004
2020

Fundamental Metrics

Financial Performance
Metric
HLF
OGN
Price
$15.50
$6.40
Analyst Decision
Strong Buy
Hold
Analyst Count
5
4
Target Price
$17.00
$11.75
AVG Volume (30 Days)
1.7M
3.1M
Earning Date
05-21-2026
05-14-2026
Dividend Yield
N/A
1.23%
EPS Growth
N/A
N/A
EPS
2.20
0.72
Revenue
$5,037,500,000.00
$6,216,000,000.00
Revenue This Year
$4.91
$0.42
Revenue Next Year
$3.90
$1.67
P/E Ratio
$7.13
$8.99
Revenue Growth
0.89
N/A
52 Week Low
$6.20
$6.18
52 Week High
$20.40
$15.88

Technical Indicators

Market Signals
Indicator
HLF
OGN
Relative Strength Index (RSI) 40.97 31.58
Support Level $14.59 $6.18
Resistance Level $17.80 $7.87
Average True Range (ATR) 0.77 0.22
MACD -0.36 -0.04
Stochastic Oscillator 17.61 11.52

Price Performance

Historical Comparison
HLF
OGN

About HLF Herbalife Ltd.

Herbalife Ltd is a health and wellness company. It provides health and wellness products in 95 markets through a direct-selling business model. Its product categories include Weight Management, Targeted Nutrition, Energy, Sports and Fitness, Outer Nutrition, and Literature, Promotional, and Other. Weight Management generates the majority of revenue, with products such as meal replacements, protein shakes, drink mixes, weight loss enhancers, and healthy snacks. Products are manufactured at facilities in Changsha and Suzhou, China; Lake Forest, California; and Winston-Salem, North Carolina, as well as by third-party providers. Revenues reflect sales to Members across North America, Latin America, EMEA, Asia Pacific, and China.

About OGN Organon & Co.

Organon & Cois a globalised healthcare company with a mission to deliver impactful medicines and solutions for a healthier every day. Its operations include the following product portfolios: Women's Health: Itbwomen's health portfolio of products is sold by prescription mainly in two therapeutic areas: contraception, with key brands such as Nexplanon, and fertility, with key brands such as Follistim. other women's health products include the Jada, which is intended to provide control and treatment of abnormal postpartum uterine bleeding or hemorrhage when conservative management is warranted. The General Medicines portfolio includes biosimilars and established brands. Companies' current biosimilars portfolio spans across immunology and oncology-related treatments.

Share on Social Networks: